| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G/A |
| 06 Nov 2026 |
Form 4: DeSimone John, Interim CEO
Granted 34,593 Stock Appreciation Rights |
| 06 Nov 2026 |
Form 4: Schaefer Scott Stephen, Chief Financial Officer
Granted 3,391 Stock Appreciation Rights |
| 06 Nov 2026 |
Form 3: Schaefer Scott Stephen, Chief Financial Officer
Holds 2,500 shares of Common Stock |
| 02 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
LOS ANGELES, November 2, 2026 – Herbalife Ltd. (NYSE: HLF) today reported financial results for the third quarter ended September 30, 2026: |
| 02 Nov 2026 | 10-Q |
| 30 Oct 2026 | SCHEDULE 13G/A |
| 31 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 31, 2026, the Company announced that Stephan Gratziani will transition from his role as Chief Executive Officer, effective October 31, 2026. |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 05 Aug 2026 |
Form 4: Lamberti Frank, Chief Commercial Officer
Gave up 1,710 shares to cover exercise price or tax ($21.9K) |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
Advances Personalized Nutrition with Bioniq launch; CFO John DeSimone to Retire at Year-End; Scott Schaefer Named Successor |
| 05 Aug 2026 | 10-Q |
| 04 Jun 2026 |
Form 4: L'Helias Sophie, Director
Bought 1,200 shares ($13.6K) |
| 20 May 2026 |
Form 4: Hicks Troy, Chief Operating Officer
Sold 38,377 shares ($496K) · Received 83,270 shares by exercise or conversion ($776K) · Gave up 72,626 shares to cover exercise price or tax ($914K) · 1 more |
| 20 May 2026 |
Form 3/A: Walsh Des, Director
Holds 50,000 shares of Common Stock |
| 19 May 2026 | 144 |
| 18 May 2026 | 144 |
| 15 May 2026 | SCHEDULE 13G/A |
| 12 May 2026 |
Form 4: Lamberti Frank, Chief Commercial Officer
Sold 7,937 shares ($110K) · Sold 134,982 shares ($1.82M) |
Loading...